Association of estrogen receptor-α A908G (K303R) mutation with breast cancer risk

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 1, 2013, Pages 39-49

  Abbasi, Sakineh ^a   Rasouli, Mina ^b   Nouri, Mehrnaz ^c   Kalbasi, Samira ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Breast cancer; Estrogen receptor; Lymph node metastasis; Mutation; PCR SSCP

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER STAGING; CODON; CONTROLLED STUDY; DNA SEQUENCE; ER ALPHA GENE; FAMILY HISTORY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; ONCOGENE; RISK ASSESSMENT; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 84870372461     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Screening for Breast Cancer. 2007. Available at: http://www.who. int/cancer/detection/ breastcancer/en/
2. Behjati F, Atri M, Najmabadi H, Nouri K, Zamani M, Mehdipour P. Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis. Pathol Oncol Res 2005; 11: 157-163.
3. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multicenter study. Asian Pac J Cancer Prev 2004; 5: 24-27.
4. Lin Y, Kikuchi S, Tamakoshi K, Wakai K, Kondo T, Niwa Y, Yatsuya H, Nishio K, Suzuki S, Tokudome S, Yamamoto A, Toyoshima H, Mori M, Tamakoshi A; Japan Collaborative Cohort Study Group for Evaluation of Cancer Risk. Active smoking, passive smoking, and breast cancer risk: findings from the Japan Collaborative Cohort Study Group for Evaluation of Cancer Risk. J Epidemiol 2008; 18: 77-83.
5. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17-35.
6. Herynk MH, Parra I, Cui Y, Beyer A, Wu MF, Hilsenbeck SG, at al. Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer. Clin Cancer Res 2007; 13: 3235-3243.
7. Herynk MH, Hopp T, Cui Y, Beyer A, Wu MF, Hilsenbeck SG, et al. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions. Breast Cancer Res Treat 2010; 122: 381-393.
8. Barone I, Brusco L, Fuqua SA. Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res 2010; 16: 2702-2708.
9. Iwao K, Miyoshi Y, Egawa C, Ikeda N, Noguchi S. Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancer. Int J Cancer 2000; 88: 733-736.
10. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000; 21: 427-433.
11. Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD, Parl FF. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 1995; 87: 446-451.
12. Azimi C, Abbasi S. Genetic polymorphisms in the estrogen receptor-α gene codon 325(CCCTCCG) and risk of breast cancer among Iranian women: a case control study. Med J Islamic Republic of Iran 2009; 23: 75-82.
13. Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR. Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 2001; 95: 271-275.
14. Abbasi S. Polymorphisms in estrogen receptor-alpha and beta genes in breast cancer patients from Imam Khomeini Hospital. In [Ph. D thesis] Malaysia: 2008; Universiti Putra Malaysia.
15. Abbasi S, Azimi C, Otman F, Noori Daloii MR, Ashtiani ZO, Mojarrad M, Oskouei SA, Nejad FM, Ismail P. (ESR1) gene codon 10 (T392C) polymorphism in Iranian women with breast cancer: a case control study. Trends Mol Scie 2009; 1: 1
16. Abbasi S, Ismail P, Othman F, Rosli R, Azimi C. Estrogen receptor-α (ESR1) gene, codon 594 (G3242A) polymorphism among Iranian women with breast cancer: a case control study. Asian J Scie Res 2009; 2: 51-60.
17. Abbasi S. Estrogene Receptor-Beta Gene Polymorphism in women with Breast Cancer at the Imam Khomeini Hospital Complex, Iran. BMC Med Genet 2010; 11: 109.
18. Vasconcelos A, Medeiros R, Veiga I, Pereira D, Carrilho S, Palmeira C, et al. Analysis of estrogen receptor polymorphism in codon 325 by PCRSSCP in breast cancer: association with lymph node metastasis. Breast J 2002; 8: 226-229.
19. Slattery ML, Sweeney C, Herrick J, Wolff R, Baumgartner K, Giuliano A, Byers T. ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res Treat 2007; 105: 327-335.
20. Einarsdóttir K, Darabi H, Li Y, Low YL, Li YQ, Bonnard C, Sjölander A, Czene K, Wedrén S, Liu ET, Hall P, Humphreys K, Liu J. ESR1 and EGF genetic variation in relation to breast cancer risk and survival. Breast Cancer Res 2008; 10: R15.
21. González-Zuloeta Ladd AM, Vásquez A, Siemes C, Hofman A, Stricker BH, Pols HA, Uitterlinden AG, van Duijn CM. Estrogen receptor α polymorphisms and postmenopausal breast cancer risk. Breast Cancer Research and Treatment 2008; 107: 415-419.
22. Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE, Hopp T, Hilsenbeck S, Mohsin S, O'Connell P, Allred DC. A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 2000; 60: 4026-4029.
23. Fuqua SA. The role of estrogen receptors in breast cancer metastasis. J Mammary Gland Biol Neoplasia 2001; 6: 407-417.
24. Hopp TA, Allred DC, Mohsin S, Hilsenbeck SG, Nawaz Z, Pestell RG, et al. A hypersensitive estrogen receptor a protein in breast cancer. In Proceedings of the 92nd Annual Meeting of the American Association of Cancer Research: 24-28 2001; New Orleans. Philadelphia: AACR; 2001; 4806.
25. Won Jeong K, Chodankar R, Purcell DJ, Bittencourt D, Stallcup MR. Gene-Specific Patterns of Coregulator Requirements by Estrogen Receptor-α in Breast Cancer Cells. Mol Endocrinol 2012; 26: 955-966.
26. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL. Gene expression patterns of breast carcinomas distinguishes tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-10874.
27. Santarpia L, Qi Y, Stemke-Hale K, Wang B, Young EJ, Booser DJ, et al. Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers. Breast Cancer Res Treat 2012.
28. Zubairy S, Cui Y, Fuqua SA. The K303R estrogen receptor alpha breast cancer mutant generates a new Akt kinase site. Proc Am Assoc Cancer Res 2004; 45: 659.
29. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005; 11: 5678-5685.
30. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, West M, Nevins JR, Huang AT. Gene expression predictors of breast cancer outcomes. Lancet 2003; 361: 1590-1596. 36. Carey LA, Perou CM, Livasy CA. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
31. Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM. Estrogen-regulated genes predict survival in hormone receptorpositive breast cancers. J Clin Oncol 2006; 24: 1656-1664.
32. Barone I, Cui Y, Herynk MH, Rodriguez AC, Giordano C, Selever J. Expression of the K303R Estrogen Receptor α Breast Cancer Mutation Induces Resistance to an Aromatase Inhibitor via Addiction to the PI3K/Akt Kinase Pathway. Cancer Res 2009; 69: 4724-4732.
33. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson JA. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007; 87: 905-931.
34. Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Jänicke F, Sauter G, Simon R. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 2007; 39: 655-660.
35. Su D, Fu X, Fan S, Wu X. Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells. Am J Pathol 2012; 180: 1189-1201.
36. Cizkova M, Susini A, Vacher S, Clairac GC, Andrieu C, Driouch K, Fourme E, Lidereau R, Bièche I. PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups. Breast Cancer Res 2012; 14: R28.
37. Shaaban AM, Sloane JP, West CR, Foster CS. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor alpha and Ki-67 expression. Am J Surg Path 2002; 160: 597-604.
38. Kang HJ, Kim SW, Kim HJ, Ahn SJ, Bae JY, Park SK, Kang D, Hirvonen A, Choe KJ, Noh DY. Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Lett 2002; 178: 175-180.
39. Conway K, Edmiston SN, Cui LJ, Drouin SS, Pang J, He M, Tse CK, Geradts J, Dressler L, Liu ET, Millikan R, Newman B. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res 2002; 62: 1987-1995.
40. Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Reproductive factors in relation to breast cancer characterized by p53 protein expression. Cancer Causes Control 2003; 14: 609-618.
41. Terry MB, Gammon MD, Schoenberg JB, Brinton LA, Arber N, Hibshoosh H. Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev 2002; 11: 1100-1103.
42. Tsakountakis N, Sanidas E, Stathopoulos E, Kafousi M, Anogiannaki N, Georgoulias V, Tsiftsis DD. Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status. BMC Womens Health 2005; 5: 1-9.
43. Kim RS, Avivar-Valderas A, Estrada Y, Bragado P, Sosa MS, Aguirre-Ghiso JA, Segall JE. Dormancy signatures and metastasis in estrogen receptor positive and negative. Breast Cancer. 2012; 7: e35569.
44. Conway K, Parrish E, Edmiston SN, Dawn T, Tse CK, Geradts J. The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study. Breast Cancer Res 2005; 7: R871-R880.
45. Conway K, Parrish E, Edmiston S N, Tolbert D, Tse CK, Moorman P, Newman B, Millikan RC. Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation. Breast Cancer Res 2007; 9: R36.